🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A great highlight of our recent work by Yexin Yang et al in the Science Magazine newsletter, written by Christie Wilcox, "Ghosts of viruses past could point to a way of combating all sorts of viruses" 👻 Link to our original paper here science.org/doi/10.1126/sc… Newsletter here

Check it out! TompkinsLab partnering with U.S. FDA Keep up the excellent research! 🐮🦠🔬 CEIRRNetwork #Mustread #collaborations #H5N1 #Research #PublicHealth 🌎🤝📚

Dr. Charles Russell, a member of CIVR-HRP, studies the mechanism of HA acid-induced activation at St. Jude Research. He works with a variety of CIVICs researchers, strengthening the collaboration of the program. Dr. Russell hopes to visit every continent! #meetCIVICs

CDC continues to share regular updates on the current #birdflu situation in the U.S., including updating a case count table three times weekly. The table also shows total cases by state and source of exposure.    Read more: bit.ly/3BMOL9V

Meet the Duke Vaccine and Trials Unit! As part of the Duke CIVICs Clinical Core, DVTU evaluates strategies aimed at the control of infectious diseases as well as the safety and effectiveness of vaccines. They encourage junior scientists to be persistent! #meetCIVICs Duke Human Vaccine Institute

Abstract submission now open! The #19vaccinecongress will take place from 7-10 September 2025 at the Kyoto International Conference Center, Kyoto, Japan. Submit your research here by 2 May 2025 spkl.io/6010fr6mk

#H5N1 #birdflu is spreading in poultry and cows. It’s rare, but people can become infected too. Be careful working with animals that could be infected. Find out what precautions you can take to work safely around animals at: bit.ly/4dADJBK

Great work is being done by NIAID CIVICs on new flu vaccines and CEIRRNetwork who are studying ways to better deal with seasonal and pandemic influenza. CEIRR: ceirr-network.org CIVICs: niaidcivics.org #FluChat

Unexpected: Serologic evidence of H5N1 infection in horses in Mongolia. 10 horses from 24 herds, 3 times per year were tested, with 9 positive using H5 ELISA. No signs of disease. 👉wwwnc.cdc.gov/eid/article/31…

Cosette Schneider, PhD Candidate and member of UMB CC, conducts research to dissect out the functional roles of cellular and humoral immunity against neuraminidase. When it's time for lab chores, you may find Cosette restocking and organizing the tissue culture room! #meetCIVICs

Courtney Page was first inspired to pursue an education in science during her AP chemistry class! She is now a PhD Candidate at Wake Forest University School of Medicine and a member of DCVC. Her research is aimed toward developing a novel vaccine for newborns. #meetCIVICs

Congrats Grace, Denzel & Eric on their Expert Opinion in Drug Delivery editorial on Ace-DEX vaccines! 🥳 doi.org/10.1080/174252… UNC Pharmacy Pharmacoengineering & Mol Pharmaceutics (DPMP UNC)

Published article now available open access! nature.com/articles/s4146… Updates from pre-print: 1. High resolution cryo-EM structure of H5 with a receptor analog and the broadly neutralizing antibody CR9114 (PDB: 9DWE) 2. Updated analyses showing the role of T199I on RBS flexibility

Dylan McClung, Scientific Communications Lead for the SDMCC, works diligently to highlight CIVICs through a variety of media channels. Dylan’s passion for #SciComm shines through when hosting CIVICs webinars. Maybe we'll see him on a reality TV show in the future! #meetCIVICs

Some collaborative NIAID CIVICs work w/ cGAMP Ace-DEX MPs. "Multi-COBRA hemagglutinin formulated w/ cGAMP MPs elicits protective immune responses against influenza viruses" Open access: journals.asm.org/doi/10.1128/ms… Pharmacoengineering & Mol Pharmaceutics (DPMP UNC) UNC Pharmacy @dyhendy98

Meet Associate Scientist and Process Engineer with Duke Human Vaccine Institute, David Clarke! He has been working with the DHVI Good Manufacturing Program for seven years. He encourages junior scientists to use any opportunity for hands-on, experiential learning. #meetCIVICs

Member of UMB CIVICs Clinical Core and Associate Professor, Franklin Toapanta, studies the roles of local and systemic cellular immune components in response to influenza. Inequities in vaccine accessibility inspired him to go into science and pursue vaccine research. #meetCIVICs

Meet Dr. Kristin Wiggins from Stacey Schultz-Cherry group at St. Jude Graduate School of Biomedical Sciences who participated in the CIVICs Collaborative Training Program. Learn about her research on COBRA-vaccines, CD4+ T-cells, and experiences in the program here: ow.ly/yihR50UHfTC #meetCIVICs

Tomorrow is the last day to submit your abstract to our Influenza Vaccine Innovation program! We’re seeking to develop novel influenza #vaccines that can provide broader and longer-lasting protection against pandemic #flu Submit by 12 pm ET on 1/20: sam.gov/opp/8f4d63db54…